US Stock MarketDetailed Quotes

TNGX Tango Therapeutics

Watchlist
  • 3.920
  • +0.290+7.99%
Close Nov 22 16:00 ET
  • 3.980
  • +0.060+1.53%
Pre 07:58 ET
421.08MMarket Cap-3408P/E (TTM)

Tango Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
8.15%11.61M
36.15%19.88M
12.23%6.47M
46.93%36.53M
-15.29%5.43M
55.09%10.73M
152.95%14.6M
0.14%5.77M
-32.89%24.86M
12.16%6.41M
Operating revenue
8.15%11.61M
36.15%19.88M
12.23%6.47M
46.93%36.53M
-15.29%5.43M
55.09%10.73M
152.95%14.6M
0.14%5.77M
-32.89%24.86M
12.16%6.41M
Cost of revenue
Gross profit
Operating expense
22.35%44.49M
30.60%49.43M
35.15%48.73M
10.87%150.7M
9.37%40.44M
-1.32%36.36M
22.19%37.85M
15.79%36.05M
42.74%135.93M
33.49%36.98M
Selling and administrative expenses
21.86%11.22M
17.43%10.77M
33.05%10.66M
18.24%35.5M
15.44%9.11M
13.71%9.21M
26.85%9.17M
17.72%8.01M
70.64%30.03M
30.02%7.89M
-General and administrative expense
21.86%11.22M
17.43%10.77M
33.05%10.66M
18.24%35.5M
15.44%9.11M
13.71%9.21M
26.85%9.17M
17.72%8.01M
70.64%30.03M
30.02%7.89M
Research and development costs
22.52%33.26M
34.82%38.65M
35.76%38.07M
8.77%115.2M
7.73%31.34M
-5.55%27.15M
20.77%28.67M
15.24%28.04M
36.41%105.91M
34.47%29.09M
Operating profit
-28.30%-32.88M
-27.12%-29.55M
-39.52%-42.26M
-2.79%-114.17M
-14.55%-35.01M
14.36%-25.63M
7.76%-23.25M
-19.33%-30.29M
-90.88%-111.07M
-39.04%-30.57M
Net non-operating interest income expense
-3.37%1.81M
42.83%2.07M
107.07%2.2M
354.60%6.62M
278.34%2.24M
434.86%1.87M
388.22%1.45M
386.70%1.06M
194.14%1.46M
201.53%591K
Non-operating interest income
-3.37%1.81M
42.83%2.07M
107.07%2.2M
354.60%6.62M
278.34%2.24M
434.86%1.87M
388.22%1.45M
386.70%1.06M
194.14%1.46M
201.53%591K
Other net income (expense)
29.19%1.96M
73.33%2M
79.46%2.18M
298.12%5.94M
113.13%2.06M
189.48%1.51M
2,202.00%1.15M
2,689.36%1.22M
702.02%1.49M
1,293.83%967K
Other non- operating income (expenses)
29.19%1.96M
73.33%2M
79.46%2.18M
298.12%5.94M
113.13%2.06M
189.48%1.51M
2,202.00%1.15M
2,689.36%1.22M
702.02%1.49M
1,293.83%967K
Income before tax
-30.90%-29.11M
-23.44%-25.49M
-35.23%-37.87M
6.02%-101.61M
-5.88%-30.72M
23.44%-22.24M
16.93%-20.65M
-11.11%-28.01M
-86.60%-108.12M
-32.65%-29.01M
Income tax
134.78%54K
1.56%65K
40K
148.15%134K
-7.84%47K
23K
2,033.33%64K
0
-81.51%54K
-71.19%51K
Net income
-31.01%-29.17M
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
Net income continuous Operations
-31.01%-29.17M
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
Minority interest income
Net income attributable to the parent company
-31.01%-29.17M
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-31.01%-29.17M
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
Basic earnings per share
-17.39%-0.27
-4.35%-0.24
-9.37%-0.35
12.20%-1.08
9.09%-0.3
30.30%-0.23
17.86%-0.23
-10.34%-0.32
-30.85%-1.23
-32.00%-0.33
Diluted earnings per share
-17.39%-0.27
-4.35%-0.24
-9.37%-0.35
12.20%-1.08
9.09%-0.3
30.30%-0.23
17.86%-0.23
-10.34%-0.32
-30.85%-1.23
-32.00%-0.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 8.15%11.61M36.15%19.88M12.23%6.47M46.93%36.53M-15.29%5.43M55.09%10.73M152.95%14.6M0.14%5.77M-32.89%24.86M12.16%6.41M
Operating revenue 8.15%11.61M36.15%19.88M12.23%6.47M46.93%36.53M-15.29%5.43M55.09%10.73M152.95%14.6M0.14%5.77M-32.89%24.86M12.16%6.41M
Cost of revenue
Gross profit
Operating expense 22.35%44.49M30.60%49.43M35.15%48.73M10.87%150.7M9.37%40.44M-1.32%36.36M22.19%37.85M15.79%36.05M42.74%135.93M33.49%36.98M
Selling and administrative expenses 21.86%11.22M17.43%10.77M33.05%10.66M18.24%35.5M15.44%9.11M13.71%9.21M26.85%9.17M17.72%8.01M70.64%30.03M30.02%7.89M
-General and administrative expense 21.86%11.22M17.43%10.77M33.05%10.66M18.24%35.5M15.44%9.11M13.71%9.21M26.85%9.17M17.72%8.01M70.64%30.03M30.02%7.89M
Research and development costs 22.52%33.26M34.82%38.65M35.76%38.07M8.77%115.2M7.73%31.34M-5.55%27.15M20.77%28.67M15.24%28.04M36.41%105.91M34.47%29.09M
Operating profit -28.30%-32.88M-27.12%-29.55M-39.52%-42.26M-2.79%-114.17M-14.55%-35.01M14.36%-25.63M7.76%-23.25M-19.33%-30.29M-90.88%-111.07M-39.04%-30.57M
Net non-operating interest income expense -3.37%1.81M42.83%2.07M107.07%2.2M354.60%6.62M278.34%2.24M434.86%1.87M388.22%1.45M386.70%1.06M194.14%1.46M201.53%591K
Non-operating interest income -3.37%1.81M42.83%2.07M107.07%2.2M354.60%6.62M278.34%2.24M434.86%1.87M388.22%1.45M386.70%1.06M194.14%1.46M201.53%591K
Other net income (expense) 29.19%1.96M73.33%2M79.46%2.18M298.12%5.94M113.13%2.06M189.48%1.51M2,202.00%1.15M2,689.36%1.22M702.02%1.49M1,293.83%967K
Other non- operating income (expenses) 29.19%1.96M73.33%2M79.46%2.18M298.12%5.94M113.13%2.06M189.48%1.51M2,202.00%1.15M2,689.36%1.22M702.02%1.49M1,293.83%967K
Income before tax -30.90%-29.11M-23.44%-25.49M-35.23%-37.87M6.02%-101.61M-5.88%-30.72M23.44%-22.24M16.93%-20.65M-11.11%-28.01M-86.60%-108.12M-32.65%-29.01M
Income tax 134.78%54K1.56%65K40K148.15%134K-7.84%47K23K2,033.33%64K0-81.51%54K-71.19%51K
Net income -31.01%-29.17M-23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M
Net income continuous Operations -31.01%-29.17M-23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M
Minority interest income
Net income attributable to the parent company -31.01%-29.17M-23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -31.01%-29.17M-23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M
Basic earnings per share -17.39%-0.27-4.35%-0.24-9.37%-0.3512.20%-1.089.09%-0.330.30%-0.2317.86%-0.23-10.34%-0.32-30.85%-1.23-32.00%-0.33
Diluted earnings per share -17.39%-0.27-4.35%-0.24-9.37%-0.3512.20%-1.089.09%-0.330.30%-0.2317.86%-0.23-10.34%-0.32-30.85%-1.23-32.00%-0.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data